9/11
08:08 am
mist
Milestone Pharmaceuticals (NASDAQ:MIST) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $4.00 price target on the stock.
Medium
Report
Milestone Pharmaceuticals (NASDAQ:MIST) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $4.00 price target on the stock.
9/11
07:55 am
mist
Rating for MIST
Medium
Report
Rating for MIST
9/11
07:55 am
mist
Rating for MIST
Medium
Report
Rating for MIST
9/11
05:25 am
mist
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
Medium
Report
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
9/11
05:25 am
mist
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo
Medium
Report
Milestone Pharmaceuticals initiated with an Overweight at Wells Fargo